Thermo Fisher Scientific Prices Offering of Senior Notes

WALTHAM, Mass., Sept. 25, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher“) announced today that it has priced an offering of €4.4 billion aggregate principal amount (the “Euro Offering”) of euro-denominated notes (collectively, the “Euro Notes”) and an offering of $900 million aggregate principal amount (the “USD Offering” and, together with the Euro... Read more

Thermo Fisher Scientific Introduces the DXR3 Family of Raman Spectroscopy Products

Thermo Fisher Scientific Introduces the DXR3 Family of Raman Spectroscopy Products The easy-to-use DXR3 Family expands offerings with advanced particle analysis and 3D visualization software HILLSBORO, Ore., Sept. 25, 2019 /PRNewswire/ — Thermo Fisher Scientific today unveiled the next-generation Thermo Scientific DXR3 Family of Raman Spectrometers and Microscopes. This new generation features advanced imaging and work-flow... Read more

Shimadzu’s efforts to catalyze global collaboration in Advanced Healthcare research

A highlight of Shimadzu’s global efforts to catalyze collaboration: Looking back at the Shimadzu Global Innovation Summit 2019 As part of its efforts to advance collaborations in the field of Advanced Healthcare*, Shimadzu Corporation held the “Shimadzu Global Innovation Summit 2019” from 9th-10th July. This year’s event, on the theme of “Pioneering Partnerships for Advanced... Read more

Danaher Announces Redemption Of Senior Notes

WASHINGTON, Sept. 23, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today that it will redeem all of its $500,000,000 aggregate principal amount of 2.400% Senior Notes due 2020 (the “Danaher 2020 Notes”) and all of the $375,000,000 aggregate principal amount of 5.00% Senior Notes due 2020 originally issued by Pall Corporation and subsequently guaranteed... Read more

Envista Announces IPO Closing

BREA, Calif., Sept. 20, 2019 /PRNewswire/ — Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), today announced the closing of its previously announced initial public offering (IPO) of 26,768,000 shares of its common stock at a price to the public of $22.00 per share. In connection with the IPO, the underwriters exercised in... Read more

Strategic Alliance between Murdoch University and Bruker Supports International Centre of Excellence in Metabolic Phenotyping

PERTH, Australia and BILLERICA, Mass., Sept. 20, 2019 /PRNewswire/ — Murdoch University and Bruker (Nasdaq: BRKR) today announced a strategic collaboration that will help transform the prevention and diagnosis of disease and personalised health around the world. The Murdoch-Bruker collaboration will play a key role within the Australian National Phenome Centre (ANPC)1, the international centre... Read more